"When these powerful metabolic hormones are marketed as 'lifestyle' products - fueled by social media and cheap, unregulated generics - the perception of risk is dangerously lowered
Any consideration of tirzepatide in BED must involve comprehensive psychiatric assessment and close monitoring by providers experienced in eating disorder treatment
Breaking the Plateau: What to Do if Semaglutide Is Not Working Anymore For many people, semaglutide is a game-changerhelping to reduce appetite, improve blood sugar control, and shed pounds when diet and exercise alone havent worked

During GLP-1associated weight loss, lean-mass changes are typically adaptive and preventable , not degenerative. GLP-1 Body Composition Changes: What Clinical Trials Show About Muscle Loss Clinical trials and body-composition sub-studies of semaglutide and tirzepatide consistently demonstrate: Fat mass accounts for most weight lost during treatment. Lean mass may decrease , particularly without resistance training or adequate protein intake. In many patients, the proportion of lean mass relative to total body weight is preserved or improved , because fat loss exceeds lean loss. Key clinical insight: GLP-1/GIP therapies improve overall body composition by preferentially reducing fat massnot by causing muscle breakdown. Lean mass refers to all the non-fat tissues in the bodyprimarily skeletal muscle , but also organs, bones, connective tissue, and body waterthat support metabolism, movement, and overall physical function
The human clinical trial data is thinner
People staring, like I had something severely wrong with me